Wugen has a total of 9 patents globally, out of which no patents have been granted. Of these 9 patents, more than 66% patents are active. United States of America is where Wugen has filed the maximum number of patents, followed by Taiwan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Wugen.
Wugen was founded in the year 2018. The Company operates as an agricultural biotechnology company. The Company focuses on developing off-the-shelf cellular therapies for cancer, solid tumors and hematologic malignancies.
Do read about some of the most popular patents of Wugen which have been covered by us in this article and also you can find Wugen patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Wugen patent portfolio.
How many patents does the founder and the CEO of Wugen have?
The founder Matthew Cooper has 4 patents and CEO John McKearn has 1 patent.
How many patents does Wugen have?
Wugen has a total of 9 patents globally. These patents belong to 7 unique patent families. Out of 9 patents, 6 patents are active.
How Many Patents did Wugen File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Wugen Applications Filed | Wugen Patents Granted |
| 2022 | 5 | – |
| 2021 | 2 | – |
| 2019 | 2 | – |
How many Wugen patents are Alive/Dead?
How Many Patents did Wugen File in Different Countries?
Countries in which Wugen Filed Patents
| Country | Patents |
| United States Of America | 1 |
| Taiwan | 1 |
Where are Research Centres of Wugen Patents Located?
The Research Centre for all the Wugen patents is the United States of America.
List of Wugen Patents
| Wugen Patents | Title |
| US20200147137A1 | Compositions And Methods For Treatment Of Cancer |
| WO2023288007A9 | Expansion Of Memory Natural Killer Cells |
| WO2023086810A1 | Combination Cancer Therapy With Memory Nk Cells And Anti-Cancer Bispecific Molecules |
| WO2022221844A3 | Improved Chimeric Antigen Receptors And Uses Thereof |
| WO2022173949A1 | Polypeptides And Their Use In Treatment Of Disease |
| TW202328202A | Combination Cancer Therapy With Memory Nk Cells And Anti-Cancer Bispecific Molecules |
| WO2022098756A1 | Chimeric Antigen Receptor Cell Therapy |
| WO2021202581A1 | Engineered Immune Cells For Adoptive Cell Therapy |
| WO2020097582A1 | Compositions And Methods For Treatment Of Cancer |
What are Wugen key innovation segments?
What Technologies are Covered by Wugen?
The chart below distributes patents filed by Wugen